This inventor holds 24 USPTO granted patents and 2 published patent applications and 1 EPO patent, primarily in Pharmaceutical Chemistry. Top assignee: Synta Pharmaceuticals Corporation. Active years: 2005-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Acton, MA (US) (2012)
- Brookline, MA (US) (2005 - 2015)
Company Filing History:
Years Active: 2005-2015
Areas of Expertise:
Title: **Hao Li: Innovator in Triazole Compounds and Cancer Treatment**
Introduction
Hao Li, based in Brookline, MA, is a notable inventor in the pharmaceutical field, holding an impressive portfolio of 24 patents. His groundbreaking work primarily focuses on the development of triazole compounds that have significant implications for cancer treatment.
Latest Patents
Among Hao Li's latest patents are innovations involving substituted triazole compounds that modulate Hsp90 activity. These inventions detail compositions comprising substituted triazole compounds focused on inhibiting the activity of Hsp90, which is pivotal in the treatment of hyperproliferative disorders like cancer. His methods propose administering these compounds to subjects in need, showcasing a novel approach to cancer prevention and treatment through targeted molecular interventions.
Career Highlights
Hao Li is affiliated with Synta Pharmaceuticals Corporation, an organization known for its commitment to developing innovative therapies. His work there underscores his dedication to advancing cancer research and treatment, positioning him as a key figure in pharmaceutical innovation.
Collaborations
Throughout his career, Hao has collaborated with talented colleagues, including Lijun Sun and Dinesh U Chimmanamada. Their combined expertise and efforts contribute significantly to the edge that Synta Pharmaceuticals Corporation maintains in the competitive landscape of drug development.
Conclusion
Hao Li's contributions to the field of pharmaceuticals, particularly through his patents related to triazole compounds, highlight his commitment to enhancing cancer treatment options. With a strong foundation in innovative research and collaboration with fellow experts, he remains a pivotal player in advancing therapeutic solutions for patients in need.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile